Analystreport

Mersana Therapeutics, Inc. (NASDAQ: MRSN) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana